Drug development

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations #TransCure bioServices

Unlock the full potential of your preclinical oncology studies

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. This new Guide from TransCure bioServices explores how humanized mouse models can help accelerate the successful development… Read More

#News

#Drug development #Drug discovery #Guide #Mouse models #Oncology #Preclinical investigations

Unlock the full potential of your preclinical oncology studies with a humanized mouse model

With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials. Our Guide explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments… Read More

#Intelligence #Resources

Clinical research
#Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Cell and gene therapy #Drug development #Drug discovery #mRNA-based vaccines #Roundtable

Roundtable: What will have most impact on drug discovery trends?

Hosted by DDW and supported by DNA Script, ‘Drug discovery and development trends – what will have most impact?’ will be free to attend on June 28 at 8AM PT | 11AM ET | 4PM BST | 5PM CET. Join this free roundtable… Read More

Webinar date:
Sponsored by DNA Script
#News

mRNA
#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Webinar: Where are the breakthroughs in mRNA?

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in mRNA drug discovery… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

mRNA
#Drug development #Drug discovery #mRNA #mRNA-based vaccines

Where are the breakthroughs in mRNA drug discovery and development?

In this on demand webinar, hosted by DDW and sponsored by Elegen, learn about the breakthroughs in mRNA drug discovery and development. You will hear from Carsten Rudolph, Managing Director and CEO of Ethris, Klaas Zuideveld, CEO of Versameb, as well as Matthew Hill, Founder and CEO of Elegen. What… Read More

Webinar date:
Sponsored by Elegen
#Webinars

AAV
#AAV #Azenta Life Sciences #Drug development #Drug discovery #Gene therapy #Plasmid DNA

A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. In this webinar, supported by Azenta Life Sciences, we’ll help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the… Read More

Webinar date:
Brought to you by Azenta Life Sciences
#Webinars

#AstraZeneca #Drug development #FDA #GSK #HER2 #National Institute for Health and Care Excellence (NICE) #Pfizer #Regulatory

New episode: DDW Highlights 19 June

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Regulatory approvals and industry guidelines are key to the continued development and discovery of drugs,… Read More

#News

#AstraZeneca #Drug development #FDA #GSK #HER2 #National Institute for Health and Care Excellence (NICE) #Pfizer #Regulatory

This week in drug discovery (12-16 June)  

News round-up for 5-9 June by DDW Multimedia Editor Megan Thomas.  Regulatory approvals and industry guidelines are key to the continued development and discovery of drugs, which is a common theme throughout this week’s news highlights, including an FDA approval for Pfizer, a NICE recommendation… Read More

#News

#Drug development #Drug discovery #Life science #Partnership #Pistoia Alliance

Pistoia Alliance announces Japanese R&D partnerships 

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK to enable pre-competitive collaboration in the Japanese market.   The Alliance and Matador share the vision that bringing together experts from diverse backgrounds… Read More

#News

Medical research
#Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Cell and gene therapy #Drug development #Drug discovery #mRNA-based vaccines #Roundtable

Join our roundtable on drug discovery and development trends

Hosted by DDW and sponsored by DNA Script, ‘Drug discovery and development trends – what will have most impact?’ will be free to attend on June 28 at 8AM PT | 11AM ET | 4PM BST | 5PM CET. Join this free roundtable… Read More

Webinar date:
Sponsored by DNA Script
#News

Cancer cell
#Cancer research #Chemotherapy #Drug development #National Institute for Health and Care Excellence (NICE) #Regulatory

Positive NICE recommendation for BRCAm ovarian cancer 

AstraZeneca UK announced that Lynparza (olaparib) is recommended by the National Institute for Health and Care Excellence (NICE) for maintenance treatment of BRCA-mutated relapsed, platinum-sensitive, high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer in adults who have had two or more courses of platinum-based chemotherapy.  BRCA1 and BRCA2 are… Read More

#Editor's Choice #News #Regulatory #Trending News

Drug discovery
#Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Cell and gene therapy #Drug development #Drug discovery #mRNA-based vaccines #Roundtable

Exclusive roundtable on drug discovery and development trends

Hosted by DDW and sponsored by DNA Script, ‘Drug discovery and development trends – what will have most impact?’ will be free to attend on June 28 at 8AM PT | 11AM ET | 4PM BST | 5PM CET. Join this free roundtable… Read More

Webinar date:
Sponsored by DNA Script
#News

Drug discovery
#Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Cell and gene therapy #Drug development #Drug discovery #mRNA-based vaccines

Drug discovery and development trends – what will have most impact?

Hosted by DDW and sponsored by DNA Script, watch this free roundtable on demand to learn about the biggest opportunities for the future of drug discovery and development. Roundtable panellists include Commercial Research Scientist, Dr Mark Treherne, CEO of Elevation Oncology, Joe Ferra, and CEO of BioXcel… Read More

Webinar date:
Sponsored by DNA Script
#Webinars

Protein degradation
#Drug development #Drug discovery #Guide #PROTAC #Protein degradation

Build effective protein degraders – answer these four questions

A new Guide is now available for download from NanoTemper. The development of a successful PROTAC candidate requires overcoming challenges at each stage of development. Read this guide to learn about common roadblocks, technologies to overcome them, and how to ensure you’re on the right track to building an efficient… Read More

#News

#Drug development #Drug discovery #Guide #PROTAC #Protein degradation

How to build an effective protein degrader

The development of a successful PROTAC candidate requires overcoming challenges at each stage of development. Read this guide to learn about common roadblocks, technologies to overcome them, and how to ensure you’re on the right track to building an efficient protein degrader. Download this guide to learn about: The most… Read More

#Intelligence #Resources

#Collaboration #Drug development #Drug discovery #License agreement #Mergers and acquisitions

This week in drug discovery (8-12 May)

News round-up for 8-12 May by DDW Digital Content Editor Diana Spencer. Inspired by the relaunch of PerkinElmer’s Life Science and Diagnostics business this week as Revvity, my top five news story this week all relate to new drug discovery business developments. See below for the… Read More

#News